Editorial Response: Changing Epidemiology of Nosocomial Infections in Human Immunodeficiency Virus-Infected Patients
Nosocomial infections (NIs) are a major cause of morbidity are at increased risk for NIs. However, the ability to generalize and mortality in the United States [1] . Immunosuppression, and compare these results is limited. The population studied, whether secondary to underlying disease, therapeutic agents, which predominantly consisted of male patients with AIDS or invasive devices or procedures, increases the risk of NIs.
and a mean CD4 cell count of õ200/mL, is not representative However, studies focusing on one rapidly growing immunosupof most HIV-infected patients in the United States. Without pressed population, HIV-infected patients, have had differing inclusion of a more representative group of HIV-infected paconclusions as to whether this population is at increased risk tients, both demographically and in disease severity, it is diffifor acquisition of NI.
cult to generalize results from this study to all HIV-infected patients.
Similarly, it is difficult to compare rates of NI in this HIVSee article by Frank et al. on pages 318 -20.
infected population with those of NI in all non-HIV-infected hospitalized patients without including a non-HIV-infected Although many studies have addressed the incidence and control group with a similar severity of illness. Nosocomial etiology of bacteremia in HIV-infected patients, in studies that infections can be caused either by endogenous organisms that have included hospitalized HIV-infected patients, NIs often are become invasive with increasing immunosuppression or by grouped together, and analyses are conducted without stratifibacteria introduced by exogenous sources, such as during cercation by level of immunosuppression or device exposure and tain procedures and exposures to medical devices. In the inpawithout comparison with similar non-HIV-infected controls tient population, intensive care unit (adult, pediatric, or neona-[2]. Few studies have been conducted to specifically assess the tal), burn unit, or surgical patients are at greatest risk of NI risk of and risk factors for NI in hospitalized HIV-infected because of their severity of illness, which is related to the level patients. A study of all HIV-infected patients admitted to one of immunosuppression and the increased use of medical devices hospital over 2 years found that the rate of NI was significantly in these settings [6] . Although treatment of NI in HIV-infected higher among these patients than among all other hospitalized patients is more often complicated by atypical presentation, patients (15% [32 of 210] vs. 7% [1,560 of 22,615], respeccoexisting infections, or multiple-antimicrobial resistance, tively; P Å .043) [3]; however, surprisingly, there was no HIV-infected patients appear to be prone to many of the same difference in the rate of NI in patients with AIDS and those risk factors for NI as HIV-negative patients [7] . However, care with HIV infection but without AIDS. In another prospective must be taken when reading and comparing studies of NIs in cohort study in which patients were stratified by stage of HIV HIV-infected patients with those of NIs in other populations disease (e.g., pre-AIDS/HIV-positive, AIDS, and HIV-negato ensure that the distribution of such patients by disease stage, tive) [4], rates of NI were not significantly different between types of therapy, and exposure to devices is provided so that pre-AIDS/HIV-positive and HIV-negative patients, but the incomparisons of rates of NI are valid. The degree of immunocidence of NI among both groups was significantly lower than suppression and the use of certain medical devices in a cohort that among patients with AIDS (1.18 and 1.84 cases per 1,000 of hospitalized patients can influence the rate of NI, and these hospital-days vs. 6.67 cases per 1,000 hospital-days, respecfactors should be carefully considered for inclusion in analyses tively). The investigators concluded that although HIV infecto avoid confounding in the calculation of such rates. tion does not alter the risk of development of NI, patients who Studies of bacteremia in HIV-infected patients repeatedly have progressed to AIDS are at significantly increased risk of have identified iv catheter use as a risk factor, thus emphasizing developing NI. the importance of this risk factor in both the hospital and In this issue of Clinical Infectious Diseases, Frank et al. [5] outpatient setting for HIV-infected patients and other patient report the incidence of NIs in HIV-infected patients admitted groups [8 -10] . Frank et al. [5] support this association by their to one San Francisco hospital over a 6-month period and also finding that insertion of a central venous catheter put patients examine risk factors for NI in this population. The investigators at increased risk for development of NI. It is interesting that present the overall rate of NI in their cohort and conclude that when these investigators presented data on site-specific rates their results ''suggest very strongly'' that HIV-infected patients they also found that the skin (rather than the urinary tract, the most common site of NI in the general population [1] ) was the most common site for NIs in this cohort. Although data on iv catheterization in this population were presented, the incidence Kuehnert and Jarvis CID 1997;25 (August)
Frank et al. [5] also note the presence of certain conditions In their comparison of HIV-infected patients with NIs with those without NIs, Frank et al. found that the CD4 cell counts that were significantly associated with NIs by univariate analysis, including history of reactivation of herpes simplex virus in these two groups were not significantly different; however, one wonders if the sample size of the group with NIs was too infection, B cell non-Hodgkin's lymphoma, cytomegalovirus infection, and HIV wasting syndrome. After multivariate analysmall to allow detection of a significant difference between CD4 cell counts. sis, the investigators found that only HIV wasting syndrome was associated with NI. In addition to being at risk for NI from
The study of NI in HIV-infected patients is challenging because of dynamic changes in immune status, exposures, treatthe same factors that other patients are, HIV-infected patients may be at risk for NI from other processes (caused by either ment and prophylactic strategies, and interaction between new drugs used for both treatment of HIV infection and treatment endogenous or exogenous organisms) unique to their underlying disease entity or therapeutic exposures that Frank et al.
of opportunistic infections. Improvement in the health of HIVinfected patients that is associated with the use of protease may have uncovered. However, it may be difficult to ascribe increased risk of NI to conditions such as HIV wasting syninhibitors and other new therapies is resulting in a decrease in the hospitalization of these patients and an increase in the use drome without knowing the association with other known risk factors for NI, such as level of immunosuppression, surgical of outpatient and home iv therapy; consequently, a new cohort of patients has been created who are increasingly difficult to procedures, or device exposures (often measured by central venous catheter -days, urinary catheter -days, or mechanical study in the era of increasing health care reorganization and may be very different from severely ill hospitalized HIVventilation -days). As Frank et al. carefully point out, there are a number of potential confounders that may be independent risk infected patients with end-stage disease [13] . Despite these obstacles, there remains a growing need for prospective studfactors for NI associated with these disease entities, including interventions needed for therapy and side effects of therapy ies examining rates of NI in both inpatient and outpatient HIV-infected populations and comparing these patients with (such as iv catheterization and neutropenia associated with ganciclovir therapy [a first-line treatment of cytomegalovirus infecsubsets of the HIV-infected population and the non-HIVinfected population. Only through such studies, like that of tion], respectively).
In the study by Frank et al. [5] , Staphylococcus species Frank et al. [5] , will we better understand the epidemiology of NI in HIV-infected patients so that preventive intervenwere the pathogens most commonly reported to cause skin and/or soft-tissue infection, while gram-negative organisms tions can be designed and implemented to reduce the risk of such infection. (including Pseudomonas aeruginosa) were the most common causes of pneumonia. Gram-negative rods (Enterobacter cloacae and P. aeruginosa) and enterococci were the most com- 
